Related Experiment Video
Updated: Jun 5, 2026

09:04
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
Laboratory methods for Rh immunoprophylaxis: a review.
S G Sandler1, S Sathiyamoorthy
1Georgetown University Hospital, Room M1306, Department of Laboratory Medicine, 3800 Reservoir Road, NW, Washington, DC 20007, USA.
Immunohematology
|January 11, 2011
Summary
Accurately measuring fetal Rh-positive red blood cells (RBCs) in D-negative mothers is crucial for Rh immune globulin dosing. Current methods like the rosette screen and Kleihauer-Betke assay have limitations, while flow cytometry offers precision but limited accessibility.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Clinical Laboratory Science
Background:
- Rh immune globulin (RhIG) prophylaxis requires accurate estimation of fetomaternal hemorrhage (FMH).
- Estimating FMH volume relies on quantifying fetal red blood cells (RBCs) in maternal circulation.
- Distinguishing fetal from maternal RBCs has historically used blood type or hemoglobin differences.
Purpose of the Study:
- To review laboratory methods for detecting and quantifying fetal RBCs in maternal blood.
- To assess current laboratory practices for FMH detection in US hospitals.
- To evaluate the suitability of different methods for Rh immunoprophylaxis.
Main Methods:
- Literature review of laboratory methods for fetal RBC detection.
- Analysis of College of American Pathologists Fetal RBC Detection Survey data.
- Evaluation of rosette screen, acid-elution (Kleihauer-Betke) assay, and flow cytometry.
Main Results:
- The rosette screen is widely used for D-negative mothers but unsuitable for D-positive mothers or unknown fetal D type.
- The Kleihauer-Betke assay is sensitive but tedious, inaccurate, and difficult to reproduce.
- Flow cytometry provides precise quantification but is not widely available due to logistical and fiscal barriers.
Conclusions:
- Current laboratory methods for FMH assessment present significant limitations for optimal Rh immune globulin dosing.
- The limitations of existing methods highlight a need for more accessible and accurate techniques.
- Flow cytometry shows promise for precise quantification but requires broader implementation for clinical utility.

